| Date | Form | Description | Docs | XBRL | Pages |
| 07/18/19 | 8-K | Current report filing |
|
4 | |
| 06/21/19 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/19/19 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 06/18/19 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/12/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 06/11/19 | S-3 | Registration statement for specified transactions by certain issuers |
|
137 | |
| 05/23/19 | 8-K | Current report filing |
|
25 | |
| 05/02/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...